P1. Pediatric Bacterial studies (natural history and therapuetic)

Poster Session: Pediatric Bacterial Studies

(P-445) Susceptibility and molecular characterization of isolates from a Phase 2/3, open-label, randomized, active-controlled clinical trial evaluating the safety and efficacy of imipenem/cilastatin/relebactam (IMI/REL) in pediatric participants with gram-negative (GN) bacterial infection